Not holding my breath. However, always looking for something below radar......
|
| Study Type : | Interventional (Clinical Trial) | | Actual Enrollment : | 81 participants | | Allocation: | Randomized | | Intervention Model: | Parallel Assignment | | Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) | | Primary Purpose: | Treatment | | Official Title: | A Phase 2 Placebo-Controlled, Randomized, Double Blind, Adaptive Dose Trial of the Safety and Efficacy of Inhaled AZD1419 in Adults With Eosinophilic, Moderate to Severe Asthma | | Actual Study Start Date : | October 12, 2016 | | Estimated Primary Completion Date : | September 24, 2018 | | Estimated Study Completion Date : | September 24, 2018
still listed as alive, three days ago..... astrazeneca.com |
|
